US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer

Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting Approval is based on the Phase III IMpower010 study showing adjuvant Tecentriq improved disease-free survival by more than one-third in PD-L1-positive Stage II-IIIA lung cancer, compared with best supportive care Basel, 15 October 2021 – Roche (SIX: RO, ROG; OTCQX:... Read more

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer’s disease

Gantenerumab is an investigational antibody in Phase III development for early Alzheimer’s disease (AD) Gantenerumab is the first and only anti-amyloid antibody being investigated for subcutaneous administration in late-stage trials for the treatment of AD Ongoing Phase III GRADUATE programme with gantenerumab is anticipated to deliver a comprehensive data set with expected readout in the... Read more

Utility Industry Leaders To Examine How Technology Helps Maximize Value And Serve Customers At Xylem Reach Conference

Sessions Planned For In-Person And Virtual Attendees RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 7, 2021– Xylem (NYSE:XYL) empowers utilities across the electric, gas and water industries to pave the way for future infrastructure through the adoption of smart technologies. This year’s annual Xylem ReachSM Conference will showcase the shift toward digital adoption and highlight success stories. The... Read more

PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 7, 2021– PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 assay. Qualified laboratories can immediately begin using this... Read more

EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization

Assay enabling the measurement of IgG antibodies could yield future discoveries and insights on immune responses to SARS-CoV-2 WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 5, 2021– EUROIMMUN, a PerkinElmer, Inc. company (NYSE: PKI), announced today that the U.S. Food and Drug Administration has provided Emergency Use Authorization (EUA) for its Anti-SARS-CoV-2 S1 CurveTM ELISA (IgG). This assay allows... Read more

Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance

Thermo Fisher Scientific Launches Wastewater Isolation Kit for SARS-CoV-2 Surveillance CARLSBAD, Calif., Oct. 5, 2021 /PRNewswire/ — Since the emergence of SARS-CoV-2, public health laboratories and researchers have been developing surveillance methods using wastewater to control the spread of COVID-19. The effort has helped identify asymptomatic carriers on college campuses to monitor regional spread among communities... Read more

Xylem, Dragos Partner to Bring Cybersecurity Leadership to Water Utilities

RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 4, 2021– Leading global water technology company, Xylem Inc., and Dragos, Inc., the global leader in cybersecurity for industrial controls systems (ICS)/operational technology (OT) environments, today announced they have partnered to bring best-in-class industrial cybersecurity to critical infrastructure in the water sector. The agreement will see Xylem and Dragos offering co-branded... Read more

Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology

Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology CARLSBAD, Calif., Sept. 29, 2021 /PRNewswire/ — To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its Oncomine Clinical Research Grant. The latest call for proposals aims to provide funding for... Read more

Thermo Fisher Scientific Continues Support for COVID-19 Testing on Historically Black College and University Campuses

Thermo Fisher Scientific Continues Support for COVID-19 Testing on Historically Black College and University Campuses WALTHAM, Mass., Sept. 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., (NYSE:TMO) the world leader in serving science, today announced continuing support for The Just Project, a national initiative to provide COVID-19 testing to students, faculty and staff across more than... Read more